Lynxco Group LLC

 Lynxco Group LLC contact information is shown below
Owner:LYNXCO GROUP LLC
Owner Address:7108 W Sun Dance Drive Queen Creek AZ 85142
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byLynxco Group LLC

Brand:

MOLECULAR DELIVERY SYSTEM
Description:

Natural supplements for treating depression and anxiety; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;Medical apparatus for facilitating the inhalation of pharmaceutical preparations; any CBD in the pharmaceutical preparation being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;DELIVERY SYSTEM;
Category: NATURAL SUPPLEMENTS TREATING DEPRESSION
Brand:

NEBBII
Description:

The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.;Natural supplements for treating depression and anxiety, any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;The wording NEBBII has no meaning in a foreign language.;Medical apparatus for facilitating the inhalation of pharmaceutical preparations; any CBD in the pharmaceutical preparation being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;
Category: NAME S
Brand:

NEBBII
Description:

The mark consists of Stylized word NEBBII.;The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.;Natural supplements for treating depression and anxiety; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;Color is not claimed as a feature of the mark.;The wording NEBBII has no meaning in a foreign language.;Medical apparatus for facilitating the inhalation of pharmaceutical preparations; any CBD in the pharmaceutical preparations being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;
Category: